Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1: Amended and Restated Certificate of Incorporation
- 3.3 EX-3.3: By-laws
- 4.2 EX-4.2: Third Amended and Restated Investor Rights Agreement
- 4.3 EX-4.3: Warrant to Purchase Shares of Common Stock
- 10.1 EX-10.1: 2002 Equity Incentive Plan, As Amended
- 10.3 EX-10.3: License Agreement
- 10.4 EX-10.4: License Agreement
- 10.5 EX-10.5: Exclusive License Agreement
- 10.6 EX-10.6: Sublease Agreement
- 10.7 EX-10.7: Amended and Restated Employment Agreement
- 10.8 EX-10.8: Letter Agreement
- 10.9 EX-10.9: Letter Agreement
- 10.10 EX-10.10: Letter Agreement
- 10.11 EX-10.11: Letter Agreement
- 10.12 EX-10.12: Change In Control Agreement
- 10.13 EX-10.13: Change In Control Agreement
- 10.14 EX-10.14: Change In Control Agreement
- 10.15 EX-10.15: Consulting Agreement
- 10.16 EX-10.16: Letter Agreement
- 10.17 EX-10.17: Form of Director and Officer Indemnification Agreement
- 10.18 EX-10.18: Letter Agreement
- 21.1 EX-21.1: Subsidiaries
- 23.1 EX-23.1: Consent of Ernst & Young LLP
FOLD similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 16, 2007, in the Registration Statement(Form S-1No. 333-000000) and related Prospectus of Amicus Therapeutics, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
MetroPark, New Jersey
March 30, 2007